Hydroxyapatite coating on porous silicon substrate obtained by precipitation process

Hydroxyapatite Ca₁₀(PO₄)₆(OH)₂ (HAP) is known as a bioactive and biocompatible material, HAP coatings were used to improve the biocompatible of substrate by many researcher, In this work, HAP thin films on porous silicon (PS) substrates have been prepared by aqueous precipitation method with rapid thermal annealing (RTA) processes. The HAP films had been prepared under the annealing temperature ranging from 300 to 1000 °C. By the measurement of X-ray diffraction (XRD), it was found that for the crystallinity optimization, the heat-treatment at 850–950 °C for 1 h would be favorable. Atomic force microscopy (AFM) and scanning electron microscope (SEM) measurements reveal a dense and smooth surface of the HAP film, and tightly adherence of the coating on porous silicon substrate after sintered. Thus, by this method, porous silicon could be increased its bioactivity and so that could be used in the biomedical area.     

蝎型钒氧配合物的合成、结构及量子化学研究

设计合成了两种新型的以聚类吡唑硼酸盐为配体的钒氧配合物VO(acac)[HB(pz)3](1)和VO(acac)[HB(3,5-Me2pz)3]·CH3CN(2). 运用元素分析、 红外光谱和紫外光谱对所合成的配合物进行了表征, 并用X射线衍射测定了它们的晶体结构. 同时, 采用量子化学的Hartree Fock方法和自然轨道分析方法(NBO), 使用3-21G*(6d, 7f)基组计算得到了两个分子体系的分子轨道、原子电荷以及键级, 并对其结构进行了分析.     

聚乳酸/壳聚糖纳米纤维结构形成的影响条件及其生物矿化活性

以二氧六环/冰醋酸为溶剂体系,采用相分离法制备了聚乳酸(PLA)/壳聚糖(CS)复合纳米纤维结构的组织工程支架,探讨了不同CS含量、不同凝胶温度及不同分子量对PLA/CS复合支架纳米纤维结构的影响以及支架的生物活性。结果表明,凝胶温度对PLA/CS复合材料的纳米纤维结构影响较大,且随着温度的降低,结构的微观尺寸也逐渐增大,从纳米级上升到普通的尺寸结构;CS含量对PLA/CS复合支架的基体结构影响不大;实验范围内PLA分子量对PLA/CS复合支架的纳米纤维结构有重要影响:分子量大的样品,较易得到PLA/CS复合纳米纤维结构的材料,而分子量小的样品则不能得到纳米纤维结构。另外,生物矿化实验表明CS的添加有利于PLA/CS复合材料生物活性的提高。     

A study on the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering

In order to increase the biocompatibility and bioactivity of chitosan, hydroxyapatite had been in situ combined into chitosan scaffolds. The bioactivity of the composite scaffolds was studied by examining the apatite formed on the scaffolds by incubating in simulated body fluid and the activity of preosteoblasts cultured on them. The apatite layer was assessed using scanning electronic microscope (SEM), X-ray diffraction (XRD), Fourier-Transformed Infrared spectroscopy (FTIR) and weight measurement. Composite analysis showed that after incubation in simulated body fluid on both of the scaffolds carbonate hydroxyapatite was formed. With increasing nano-hydroxyapatite content in the composite, the quantity of the apatite formed on the scaffolds increased. Compared with pure chitosan, the composite with nano-hydroxyapatite could form apatite more readily during the biomimetic process, which suggests that the composite possessed better mineralization activity. Furthermore, preosteoblast cells cultured on the apatite-coated scaffolds showed different behavior. On the apatite-coated composite scaffolds cells presented better proliferation than on apatite-coated chitosan scaffolds. In addition, alkaline phosphatase activities of cells cultured on the scaffolds in conditioned medium were assessed. The cells on composite scaffolds showed a higher alkaline phosphatase activity which suggested a higher differentiation level. The results indicated that the addition of nano-hydroxyapatite improved the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds. On the other hand, that is to say composition of substrates could affect the apatite formation on them, and pre-loaded hydroxyapatite can enhance the apatite-coating. It will also be significant in preparation of apatite-coating polymer scaffolds for bone tissue engineering.     

成骨肿瘤细胞在纳米氧化钛陶瓷表面的生物活性研究

以羟基磷灰石和氧化镁为晶粒生长抑制剂制备的纳米氧化钛陶瓷为研究对象, 采用体外成骨细胞Ros17/28与材料复合培养的方法, 通过MTT法、荧光染色法和SEM细胞形貌观察等手段综合判断细胞在材料表面的活性, 以此评价纳米氧化钛陶瓷的生物活性. 结果表明, 以羟基磷灰石为晶粒生长抑制剂的氧化钛陶瓷晶体颗粒尺寸达到纳米级, 其生物活性超出了以氧化镁为晶粒生长抑制剂的氧化钛陶瓷和纯羟基磷灰石陶瓷, 具有优异的生物相容性, 是生物活性陶瓷.     

3D printed polylactic acid nanocomposite scaffolds for tissue engineering applications

In this study, biodegradable polylactic acid (PLA) and PLA nanocomposite scaffolds reinforced with magnetic and conductive fillers, were processed via fused filament fabrication additive manufacturing and their bioactivity and biodegradation characteristics were examined. Porous 3D architectures with 50% bulk porosity were 3D printed, and their physicochemical properties were evaluated. Thermal analysis confirmed the presence of ~18 wt% of carbon nanostructures (CNF and GNP; nowonwards CNF) and ~37 wt% of magnetic iron oxide (Fe₂O₃) particles in the filaments. The in vitro degradation tests of scaffolds showed porous and fractured struts after 2 and 4 weeks of immersion in DMEM respectively, although a negligible weight loss is observed. Greater extent of degradation is observed in PLA with magnetic fillers followed by PLA with conductive fillers and neat PLA. In vitro bioactivity study of scaffolds indicate enhancement from ~2.9% (PLA) to ~5.32% (PLA/CNF) and ~ 3.12% (PLA/Fe₂O₃). Stiffness calculated from the compression tests showed decrease from ~680 MPa (PLA) to 533 MPa and 425 MPa for PLA/CNF and PLA/Fe₂O₃ respectively. Enhanced bioactivity and faster biodegradation response of PLA nanocomposites with conductive fillers make them a potential candidate for tissue engineering applications such as scaffold bone replacement and regeneration.     

Linked drug-drug conjugates based on triterpene and phenol structures. Rational synthesis,molecular properties,toxicity and bioactivity prediction

One of the tasks of modern medicinal chemistry is to produce new molecules that have interesting and desired biological effects. In addition, the synthetic procedure for obtaining these compounds should be at least partially smart and rational e.g. “Lego” and green approaches. The study focuses on the synthesis of several hybrid type compounds that are expected to be characterized by beneficial bioactivities. In order to hybridize natural triterpene oleanolic acid and phenol structures, the linker-mode concept was selected. The synthetic goal was achieved in two stages. The first concerns the rapid introduction of the halogenoacidic linker to active phenols selected as a result of microwave-ultrasonic (MW-US) assisted O-alkylation with the use of 2-halogenoacetic acid. The next stage of the synthetic studies involves the reaction of phenoxyacetic acid derivatives obtained containing an active carboxylic group with oleanolic acid/oxime units by the methods typical of triterpene chemistry. Novel linked ester- and iminoester-type triterpene derivatives with phenols (thymol, eugenol, paracetamol, nipagins, naphthols, curcumin and genistein) were obtained and characterized. Additionally, based on the analysis of numerous references and selected methods of computational chemistry (Molinspiration Cheminformatics, Osiris Property Explorer and PASS method) the molecular parameters and the preliminary anti-inflammatory and antinociceptive activity characterising these molecules as potential drugs were calculated and predicted.     

磺化壳聚糖的制备及其对生长因子活性的保护作用

以壳聚糖为基材,分别以氯磺酸、三甲胺.三氧化硫和丙磺酸内酯为磺化试剂,制备了3,6-O-磺化壳聚糖(OCS)、2-N-磺化壳聚糖(NCS)和2-N-磺丙基壳聚糖(PCS)3种磺化壳聚糖.采用红外光谱、核磁共振谱证明了磺化壳聚糖的结构,元素分析测定了磺化壳聚糖的磺化率.以组织修复过程中一种重要的活性因子——碱性成纤维细胞生长因子(bFGF)为目标因子,通过体外成纤维细胞培养实验,评价了不同磺化壳聚糖对bFGF活性的保护能力.结果显示,相对于未改性壳聚糖(CS),磺化壳聚糖对成纤维细胞的形态无显著影响.细胞活性检测结果显示,OCS和PCS对bFGF活性无明显的保护能力;NCS能有效提高bFGF促进成纤维细胞活性的能力,其对bFGF活性的保护能力可达肝素70%左右.磺化壳聚糖的bFGF活性保护能力不随磺化率的改变而变化.     

Photo-induced synthesis and in vitro biological activity of a Sansalvamide A analog

Photoinduced single electron transfer (SET) cyclization processes for synthesis of a Sansalvamide A analog containing double pharmacophores (cyclicpeptides and O-phthalimide moiety) is described to develop novel antitumor cyclopeptide drug. The resultant compound is active in drug-sensitive HeLa, HepG-2 and MCF-7 cell lines. Specifically, the title compound was found to inhibit MCF-7 cells with an IC₅₀ value of 15 μM (13.4 μg/mL), which may serve as a potential candidate for antitumor drug development.     

Structure,biological and electrochemical studies of transition metal complexes from N,S,N′ donor ligand 8-(2-pyridinylmethylthio)quinoline

The semirigid tridentate 8-(2-pyridinylmethylthio)quinoline ligand (Q1) is shown to form the structurally characterized transition metal complexes [Cu(Q1)Cl₂] (1), [Co(Q1)(NO₃)₂] (2), [Cd(Q1)(NO₃)₂] (3), [Cd(Q1)I₂] (4). [Cu(Q1)₂](BF₄)₂·(H₂O)₂ (5), [Cu(Q1)₂](ClO₄)₂·(CH₃COCH₃)₂ (6), [Zn(Q1)₂](ClO₄)₂(H₂O)₂ (7), [Cd₂(Q1)₂Br₄] (8), [Ag₂(Q1)₂(ClO₄)₂] (9), and [Ag₂(Q1)₂(NO₃)₂] (10). Four types of structures have been observed: ML-type in complexes 1–4, in which the anions Cl⁻, NO₃⁻ or I⁻ also participate in the coordination; ML₂⁻ type in complexes 5–7 without direct coordination of the anions BF₄⁻ or ClO₄⁻ and with more (Cu²⁺) or less (Zn²⁺) distorted bis-fac coordinated Q1; M₂L₂-type in complex 8, in which two Br⁻ ions act as bridges between two metal ions; and M₂(μ-L)₂-type in complexes 9 and 10, in which the ligand bridges two anion binding and Ag–Ag bonded ions. Depending on electron configuration and size, different coordination patterns are observed with the bonds from the metal ions to N_pyridyl longer or shorter than those to N_quinoline. Typically Q1 acts as a facially coordinating tridentate chelate ligand except for the compounds 9 and 10 with low-coordinate silver(I). Except for 6 and 8, the complexes exhibit distinct constraining effects against both G(+) and G(-) bacteria. Complexes 1, 3, 4, 5, 7 have considerable antifungal activities and complexes 1, 5, 7, and 10 show selective effects to restrain certain botanic bacteria. Electrochemical studies show quasi-reversible reduction behavior for the copper(II) complexes 1, 5 and 6.